• Ramy E Abdelhamid, Katalin J Kovacs, Jeffrey D Pasley, Myra G Nunez, and Alice A Larson.
• Department of Veterinary and Biomedical Sciences, University of Minnesota, 1988 Fitch Avenue Room 295, St. Paul, MN 55108, USA.
• Neuropharmacology. 2013 Sep 1; 72: 29-37.

AbstractThe exacerbation of musculoskeletal pain by stress in humans is modeled by the musculoskeletal hyperalgesia in rodents following a forced swim. We hypothesized that stress-sensitive corticotropin releasing factor (CRF) receptors and transient receptor vanilloid 1 (TRPV1) receptors are responsible for the swim stress-induced musculoskeletal hyperalgesia. We confirmed that a cold swim (26 °C) caused a transient, morphine-sensitive decrease in grip force responses reflecting musculoskeletal hyperalgesia in mice. Pretreatment with the CRF2 receptor antagonist astressin 2B, but not the CRF1 receptor antagonist NBI-35965, attenuated this hyperalgesia. Desensitizing the TRPV1 receptor centrally or peripherally using desensitizing doses of resiniferatoxin (RTX) failed to prevent the musculoskeletal hyperalgesia produced by cold swim. SB-366791, a TRPV1 antagonist, also failed to influence swim-induced hyperalgesia. Together these data indicate that swim stress-induced musculoskeletal hyperalgesia is mediated, in part, by CRF2 receptors but is independent of the TRPV1 receptor.Copyright © 2013 Elsevier Ltd. All rights reserved.

43 keywords...

hide…